Chinese Journal of Experimental Traditional Medical Formulae
Uyghur Medicine Syndrome Classification of Vitiligo and Its Medication Discipline
Author:
Affiliation:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
    Abstract:

    Objective: To collate and analyze the Uyghur medicine syndrome classification of vitiligo and its medication discipline. Method: Using retrospective analysis of sorting,clinical medical records of vitiligo treated with Uyghur medicine within recent 10 years in 5 Uyghur medicine hospitals were collected. Uyghur medical symptom classification and treatment principles,methods,prescriptions and medications of vitiligo were collated and analyzed to discover vitiligo's Uyghur medicine syndrome differentiation method and its medication discipline. Result: Among 362 cases of medical records meeting the inclusion criteria of abnormal balgham type vitiligo,there were 173 cases (47.79%) of tamsiz balgham type,followed by 46 cases (12.7%) of Gajsiman Balgham type,43 cases (11.88%) of Chuchumal Balgham type,40 cases (11.05%) of tatlik balgham type,36 cases (9.94%) of Kirtak Balgham type,and 24 cases (6.63%) of Shor Balgham type. Patients were treated with Munzij Therapy or conditioning,Mushil Therapy,oral medication,topical medications and non-drug therapy of Uyghur Medicine. Conclusion: Uyghur medicine syndrome classification and medication discipline of vitiligo received in this project is in line with the actualclinical syndrome and that provides an objective basis forstandardization of vitiligo's Uyghur medicine syndrome differentiation

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 02,2015
  • Revised:
  • Adopted:
  • Online: May 28,2015
  • Published:

Address:

Postcode:100700

Phone:010-84076882

E-mail:syfjx_2010@188.com

® 2024 All Rights Reserved

Supported by:Beijing E-Tiller Technology Development Co., Ltd.